Skip to main content

Site notifications

SOLIQUA insulin glargine (rbe) 100 units/mL and lixisenatide 50 microgram/mL solution for injection injector pen Cancelled under Section 30(1)(c) of the Act

Product name
SOLIQUA insulin glargine (rbe) 100 units/mL and lixisenatide 50 microgram/mL solution for injection injector pen
ARTG
282109
Date of effect
Decision type
Cancelled under Section 30(1)(c) of the Act

Help us improve the Therapeutic Goods Administration site